Literature DB >> 12943151

A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050.

Amanda A Honeycutt1, James P Boyle, Kristine R Broglio, Theodore J Thompson, Thomas J Hoerger, Linda S Geiss, K M Venkat Narayan.   

Abstract

This study develops forecasts of the number of people with diagnosed diabetes and diagnosed diabetes prevalence in the United States through the year 2050. A Markov modeling framework is used to generate forecasts by age, race and ethnicity, and sex. The model forecasts the number of individuals in each of three states (diagnosed with diabetes, not diagnosed with diabetes, and death) in each year using inputs of estimated diagnosed diabetes prevalence and incidence; the relative risk of mortality from diabetes compared with no diabetes; and U.S. Census Bureau estimates of current population, live births, net migration, and the mortality rate of the general population. The projected number of people with diagnosed diabetes rises from 12.0 million in 2000 to 39.0 million in 2050, implying an increase in diagnosed diabetes prevalence from 4.4% in 2000 to 9.7% in 2050.

Entities:  

Mesh:

Year:  2003        PMID: 12943151     DOI: 10.1023/a:1024467522972

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  14 in total

1.  Ethnic differences in mortality from insulin-dependent diabetes mellitus among people less than 25 years of age.

Authors:  R Lipton; G Good; T Mikhailov; S Freels; E Donoghue
Journal:  Pediatrics       Date:  1999-05       Impact factor: 7.124

2.  Implications of population growth on prevalence of diabetes. A look at the future.

Authors:  R B Helms
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

3.  The quality of health data obtained in a new survey of elderly Americans: a validation study of the proposed Medicare Beneficiary Health Status Registry (MBHSR).

Authors:  C F Turner; T K Smith; L K Fitterman; T Reilly; K Pate; M B Witt; A M McBean; J T Lessler; B H Forsyth
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1997-01       Impact factor: 4.077

4.  Evaluation of National Health Interview Survey diagnostic reporting.

Authors: 
Journal:  Vital Health Stat 2       Date:  1994-02

5.  Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota.

Authors:  E F Tierney; L S Geiss; M M Engelgau; T J Thompson; D Schaubert; L A Shireley; P J Vukelic; S L McDonough
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

6.  Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

Authors:  J P Boyle; A A Honeycutt; K M Narayan; T J Hoerger; L S Geiss; H Chen; T J Thompson
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

7.  Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.

Authors: 
Journal:  Diabetes Care       Date:  1998-02       Impact factor: 19.112

8.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

9.  Forecasting the number of diabetic patients in The Netherlands in 2005.

Authors:  D Ruwaard; R T Hoogenveen; H Verkleij; D Kromhout; A F Casparie; E A van der Veen
Journal:  Am J Public Health       Date:  1993-07       Impact factor: 9.308

10.  Cause-specific mortality in a population-based study of diabetes.

Authors:  S E Moss; R Klein; B E Klein
Journal:  Am J Public Health       Date:  1991-09       Impact factor: 9.308

View more
  37 in total

Review 1.  Mortality and morbidity trends: is there compression of morbidity?

Authors:  Eileen M Crimmins; Hiram Beltrán-Sánchez
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2010-12-06       Impact factor: 4.077

2.  System dynamics modeling for public health: background and opportunities.

Authors:  Jack B Homer; Gary B Hirsch
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

Review 3.  Epidemiology of diabetes and diabetes-related complications.

Authors:  Anjali D Deshpande; Marcie Harris-Hayes; Mario Schootman
Journal:  Phys Ther       Date:  2008-09-18

4.  Modeling transition rates using panel current-status data: how serious is the bias?

Authors:  Douglas A Wolf; Thomas M Gill
Journal:  Demography       Date:  2009-05

Review 5.  The prevention of type 2 diabetes: an overview.

Authors:  David G Marrero
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

6.  Prevalence of type 2 diabetes in Germany in 2040: estimates from an epidemiological model.

Authors:  Ralph Brinks; Teresa Tamayo; Bernd Kowall; Wolfgang Rathmann
Journal:  Eur J Epidemiol       Date:  2012-08-10       Impact factor: 8.082

7.  Projection of osteoporosis-related fractures and costs in China: 2010-2050.

Authors:  L Si; T M Winzenberg; Q Jiang; M Chen; A J Palmer
Journal:  Osteoporos Int       Date:  2015-03-12       Impact factor: 4.507

8.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

Authors:  James P Boyle; Theodore J Thompson; Edward W Gregg; Lawrence E Barker; David F Williamson
Journal:  Popul Health Metr       Date:  2010-10-22

Review 9.  Emerging drugs for the treatment of diabetic ulcers.

Authors:  Francesco Tecilazich; Thanh L Dinh; Aristidis Veves
Journal:  Expert Opin Emerg Drugs       Date:  2013-05-21       Impact factor: 4.191

10.  Ginseng on hyperglycemia: effects and mechanisms.

Authors:  John Zeqi Luo; Luguang Luo
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.